Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

20 Sökresultat.
Relevans Bedömning Nya först Gamla först

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056

- 20-09-21 - 1 Formulär, 3 Item-grupper, 53 Dataelement, 1 Språk
Item-grupper: Header, Randomization questions, Patient status assessment
Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159B9D6-FD84-2C7B-E034-0003BA3F9857

Eligibility DRKS00009676 NCT00321620 Bone Metastases - Eligibility

- 20-09-21 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 2 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00321620

Southwest Oncology Group Registration Form (S0421) NCT00134056

- 20-09-21 - 1 Formulär, 3 Item-grupper, 40 Dataelement, 1 Språk
Item-grupper: Header, Patient demographics, Miscellaneous Patient Information
Southwest Oncology Group Registration Form (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A11DF-588A-2157-E034-0003BA3F9857

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases - Radium 223 Dichloride (Alpharadin) - Screening Visit

- 13-02-17 - 1 Formulär, 9 Item-grupper, 89 Dataelement, 1 Språk
Item-grupper: Demography, Vital Signs, Prostate Cancer Classification, BPI-SF, ECOG Performance Status, Prior radiotherapy, Prior diagnostic and therapeutic procedures for prostate cancer, Hematology (with DBC), General chemistry - Serum
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form

- 28-07-15 - 1 Formulär, 5 Item-grupper, 26 Dataelement, 1 Språk
Item-grupper: Header, STATUS, TREATMENT, ARM 1 + ARM 2, COMMENTS
SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A78DC-93A4-2746-E034-0003BA3F9857

NCT00134056 Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 1 Randomization Form

- 05-07-15 - 1 Formulär, 3 Item-grupper, 22 Dataelement, 1 Språk
Item-grupper: SWOG clinical trial administrative data, Form completed by, Comments
NCT00134056 Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B4D3C-6774-37C6-E034-0003BA3F9857

Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056

- 27-06-15 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: SWOG clinical trial administrative data, Patient demographics
Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F977EF7-B9B7-51FB-E044-0003BA3F9857

CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001

- 21-06-15 - 1 Formulär, 5 Item-grupper, 23 Dataelement, 1 Språk
Item-grupper: Header, Patient demographics, Target Lesion(s) Baseline Evaluation, Non-target lesion(s) Baseline Evaluation, CCRR MODULE
CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001 Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4605F45-F7E1-0518-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056

- 12-06-15 - 1 Formulär, 3 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Header, Patient Instructions, Patient medical history
SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D64D5-FB3B-3049-E044-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0421) NCT00134056

- 12-06-15 - 1 Formulär, 6 Item-grupper, 24 Dataelement, 1 Språk
Item-grupper: Header, TARGET LESIONS, NON-TARGET DISEASE, NEW LESIONS (specify site), Symptomatic deterioration, Comments
SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159E224-5826-3109-E034-0003BA3F9857

Southwest Oncology Group S0421 Symptom Questionnaires: Step 1 Randomization Form NCT00134056

- 12-06-15 - 1 Formulär, 1 Item-grupp, 30 Dataelement, 1 Språk
Item-grupp: SWOG clinical trial symptom questionnaire
Southwest Oncology Group S0421 Symptom Questionnaires: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B296A-D2C9-33BF-E034-0003BA3F9857

Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 2 Post-Chemo Form NCT00134056

- 12-06-15 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk
Item-grupper: SWOG clinical trial administrative data, Comments
Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D56C4-48DA-2FAB-E044-0003BA3F9857

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial